REDWOOD CITY, Calif. (AP) _ Guardant Health Inc. (GH) on Thursday reported a loss of $109.7 million in its first quarter.

The Redwood City, California-based company said it had a loss of $1.09 per share. Losses, adjusted for stock option expense and non-recurring costs, were 49 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 82 cents per share.

The provider of oncology testing services posted revenue of $78.7 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $74.3 million.

Guardant Health expects full-year revenue in the range of $360 million to $370 million.

Guardant Health shares have increased 4.5% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $134.62, a rise of 67% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News